TECTONIC THERAPEUTIC, INC. (TECX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $494.11M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
- 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $478.39M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $474.16M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-96.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in CapitalUSD $471.11M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-75.00K.
TECTONIC THERAPEUTIC, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD | Additional Paid in Capital, Common Stock USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.00K | $494.11M | $0.00 | $-270.26M | $223.85M | 3 month · $4.01M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $2.00K | $478.39M | $0.00 | $-247.98M | $230.42M | 3 month · $3.21M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $2.00K | $474.16M | $-96.00K | $-222.74M | $251.33M | 12 month · $10.50M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $2.00K | $471.11M | $-75.00K | $-203.51M | $267.53M | 3 month · $2.82M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $2.00K | $468.29M | $-49.00K | $-184.48M | $283.77M | 3 month · $2.59M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $2.00K | $465.52M | $2.00K | $-164.49M | $301.04M | 3 month · $2.10M | 3 month · $9.30M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $2.00K | $289.35M | $9.00K | $-148.59M | $140.78M | 12 month · $3.49M | 12 month · $9.30M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $2.00K | $286.65M | $-77.00K | $-136.21M | $150.36M | 3 month · $1.65M | 9 month · $9.90M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $2.00K | $284.92M | $-61.00K | $-118.50M | $166.37M | 3 month · $403.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $4.00K | (m) | (m) | $-484.08M | $-99.57M | 3 month · $321.00K | (m) | $572.92M | (m) | (m) |
| 2023-12-31 | $0.00 | $0.00 | $5.98M | $-11.00K | $-90.60M | $-84.64M | 12 month · $1.12M | (m) | $572.01M | (m) | (m) |
| 2023-09-30 | (m) | $4.00K | (m) | (m) | $-468.49M | $-79.78M | 3 month · $275.00K 9 month · $6.28M | (m) | $571.34M | (m) | (m) |
| 2023-06-30 | (m) | $4.00K | (m) | (m) | $-446.91M | $-70.00M | 3 month · $277.00K 6 month · $4.06M | (m) | $568.95M | (m) | (m) |
| 2023-03-31 | (m) | $4.00K | (m) | (m) | $-514.39M | $-59.82M | 3 month · $275.00K | (m) | $567.38M | (m) | (m) |
| 2022-12-31 | $0.00 | $4.00K | (m) | (m) | $-489.43M | $-45.65M | 12 month · $11.52M | (m) | $564.80M | (m) | (m) |
| 2022-09-30 | (m) | $4.00K | (m) | (m) | $-464.40M | $98.09M | 3 month · $2.66M 9 month · $9.27M | (m) | $562.48M | (m) | (m) |
| 2022-06-30 | (m) | $4.00K | (m) | (m) | $-441.43M | $118.34M | 3 month · $3.23M 6 month · $6.61M | (m) | $559.77M | (m) | (m) |
| 2022-03-31 | (m) | $4.00K | (m) | (m) | $-413.38M | $143.16M | 3 month · $3.38M | (m) | $556.53M | (m) | (m) |
| 2021-12-31 | $0.00 | $4.00K | (m) | (m) | $-383.54M | $169.48M | 12 month · $18.58M | (m) | $553.01M | (m) | (m) |
| 2021-09-30 | (m) | $4.00K | (m) | (m) | $-355.31M | $193.57M | 3 month · $5.17M 9 month · $14.49M | (m) | $548.88M | 9 month · $67.00K | (m) |
| 2021-06-30 | (m) | $4.00K | (m) | (m) | $-322.70M | $220.99M | 3 month · $4.69M 6 month · $9.33M | (m) | $543.69M | 3 month · $67.00K 6 month · $67.00K | (m) |
| 2021-03-31 | (m) | $4.00K | (m) | (m) | $-291.31M | $232.93M | 3 month · $4.63M | (m) | $524.24M | (m) | (m) |
| 2020-12-31 | (m) | $4.00K | (m) | (m) | $-264.42M | $254.34M | 12 month · $15.63M | (m) | $518.76M | (m) | (m) |
| 2020-09-30 | (m) | $4.00K | (m) | (m) | $-236.28M | $207.87M | 3 month · $4.80M 9 month · $11.53M | (m) | $444.15M | (m) | (m) |
| 2020-06-30 | (m) | $4.00K | (m) | (m) | $-199.50M | $239.79M | 3 month · $3.90M 6 month · $6.72M | (m) | $439.29M | (m) | (m) |
| 2020-03-31 | (m) | $4.00K | (m) | (m) | $-170.68M | $256.52M | 3 month · $2.82M | (m) | $427.20M | 3 month · $419.00K | (m) |
| 2019-12-31 | (m) | $3.00K | (m) | (m) | $-144.70M | $186.01M | 12 month · $6.80M | (m) | $330.71M | (m) | (m) |
| 2019-09-30 | (m) | $3.00K | (m) | (m) | $-122.04M | $206.76M | 3 month · $1.80M | (m) | $328.80M | (m) | (m) |
| 2019-06-30 | (m) | $2.00K | (m) | (m) | $-104.90M | $92.63M | 3 month · $1.66M | (m) | $197.53M | (m) | (m) |
| 2019-03-31 | (m) | $2.00K | (m) | (m) | $-88.84M | $106.79M | 3 month · $1.46M | (m) | $195.63M | (m) | (m) |
| 2018-12-31 | (m) | $2.00K | (m) | (m) | $-71.74M | $122.18M | 12 month · $2.20M | (m) | $193.92M | (m) | 12 month · $197.00K |
| 2018-09-30 | (m) | $2.00K | (m) | (m) | $-55.72M | $137.11M | 3 month · $550.00K | (m) | $192.82M | 3 month · $168.00K | (m) |
| 2018-06-30 | (m) | $2.00K | (m) | (m) | $-44.13M | $148.32M | 3 month · $457.00K | (m) | $192.44M | (m) | 3 month · $197.00K |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | $-33.51M | 3 month · $109.00K | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | $-23.47M | $-23.14M | 12 month · $109.00K | (m) | $339.00K | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $-4.58M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |